These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7510890)
1. Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase. Chung TD; Cianci C; Hagen M; Terry B; Matthews JT; Krystal M; Colonno RJ Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2372-6. PubMed ID: 7510890 [TBL] [Abstract][Full Text] [Related]
2. Solid phase synthesis of 5'-diphosphorylated oligoribonucleotides and their conversion to capped m7Gppp-oligoribonucleotides for use as primers for influenza A virus RNA polymerase in vitro. Brownlee GG; Fodor E; Pritlove DC; Gould KG; Dalluge JJ Nucleic Acids Res; 1995 Jul; 23(14):2641-7. PubMed ID: 7544461 [TBL] [Abstract][Full Text] [Related]
3. RNA polymerase of influenza virus. IV. Catalytic properties of the capped RNA endonuclease associated with the RNA polymerase. Kawakami K; Mizumoto K; Ishihama A Nucleic Acids Res; 1983 Jun; 11(11):3637-49. PubMed ID: 6856461 [TBL] [Abstract][Full Text] [Related]
4. Recognition of cap structure by influenza B virus RNA polymerase is less dependent on the methyl residue than recognition by influenza A virus polymerase. Wakai C; Iwama M; Mizumoto K; Nagata K J Virol; 2011 Aug; 85(15):7504-12. PubMed ID: 21593178 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of modified 5'-capped short RNA fragments on influenza virus RNA polymerase gene expression. Tado M; Abe T; Hatta T; Ishikawa M; Nakada S; Yokota T; Takaku H Antivir Chem Chemother; 2001 Nov; 12(6):353-8. PubMed ID: 12018680 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of modified capped RNA substrates on influenza virus transcription. Cianci C; Colonno RJ; Krystal M Virus Res; 1997 Jul; 50(1):65-75. PubMed ID: 9255936 [TBL] [Abstract][Full Text] [Related]
8. RNA polymerase of influenza virus. II. Influence of oligonucleotide chain length on the priming activity of RNA synthesis by virion-associated RNA polymerase. Kawakami K; Ishihama A; Ohtsuka E; Tanaka T; Takashima H; Ikehara M J Biochem; 1981 Jun; 89(6):1759-68. PubMed ID: 7287650 [TBL] [Abstract][Full Text] [Related]
9. Capped mRNAs may stimulate the influenza virion polymerase by allosteric modulation. Penn CR; Mahy BW Virus Res; 1984 Jan; 1(1):1-13. PubMed ID: 6531999 [TBL] [Abstract][Full Text] [Related]
10. RNA primers and the role of host nuclear RNA polymerase II in influenza viral RNA transcription. Krug RM; Bouloy M; Plotch SJ Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):359-70. PubMed ID: 6103553 [TBL] [Abstract][Full Text] [Related]
11. Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors. Pflug A; Gaudon S; Resa-Infante P; Lethier M; Reich S; Schulze WM; Cusack S Nucleic Acids Res; 2018 Jan; 46(2):956-971. PubMed ID: 29202182 [TBL] [Abstract][Full Text] [Related]
12. Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. Fechter P; Mingay L; Sharps J; Chambers A; Fodor E; Brownlee GG J Biol Chem; 2003 May; 278(22):20381-8. PubMed ID: 12646557 [TBL] [Abstract][Full Text] [Related]
13. The role of template-primer interactions in cleavage and initiation by the influenza virus polymerase. Hagen M; Tiley L; Chung TD; Krystal M J Gen Virol; 1995 Mar; 76 ( Pt 3)():603-11. PubMed ID: 7534813 [TBL] [Abstract][Full Text] [Related]
15. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Plotch SJ; Bouloy M; Ulmanen I; Krug RM Cell; 1981 Mar; 23(3):847-58. PubMed ID: 6261960 [TBL] [Abstract][Full Text] [Related]
16. Repetitive prime-and-realign mechanism converts short capped RNA leaders into longer ones that may be more suitable for elongation during rice stripe virus transcription initiation. Yao M; Zhang T; Zhou T; Zhou Y; Zhou X; Tao X J Gen Virol; 2012 Jan; 93(Pt 1):194-202. PubMed ID: 21918010 [TBL] [Abstract][Full Text] [Related]
17. Characterization of PA-N terminal domain of Influenza A polymerase reveals sequence specific RNA cleavage. Datta K; Wolkerstorfer A; Szolar OH; Cusack S; Klumpp K Nucleic Acids Res; 2013 Sep; 41(17):8289-99. PubMed ID: 23847103 [TBL] [Abstract][Full Text] [Related]
18. Preferential use of RNA leader sequences during influenza A transcription initiation in vivo. Geerts-Dimitriadou C; Goldbach R; Kormelink R Virology; 2011 Jan; 409(1):27-32. PubMed ID: 21030059 [TBL] [Abstract][Full Text] [Related]
19. Functional analysis of influenza RNA polymerase activity by the use of caps, oligonucleotides and polynucleotides. Stridh S; Oberg B; Chattopadhyaya J; Josephson S Antiviral Res; 1981 Jun; 1(2):97-105. PubMed ID: 7337430 [TBL] [Abstract][Full Text] [Related]
20. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. Watanabe K; Handa H; Mizumoto K; Nagata K J Virol; 1996 Jan; 70(1):241-7. PubMed ID: 8523532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]